Fluids Handling News & Events

MattenPlant Launches Cold WFI System in Southeast Asia

Phil Black - PII Editor 1 hour ago

26 2 minutes read

Key points

Listen to this article

MattenPlant Pte Ltd, a water and wastewater treatment expert based in Singapore, has just rolled out its exciting new initiative: the Pharmaceutical Water for Injection (Cold WFI) system. This groundbreaking system is touted as the first of its kind in Southeast Asia, utilizing innovative membrane technology for local manufacturing.

This initiative marks a significant step for Matten as it ventures into the realm of pharmaceutical water solutions. You can catch a glimpse of this cutting-edge technology at Booth B2-D20 during the Singapore International Water Week 2026, where pharmaceutical manufacturers, engineering consultants, and other industry players can dive deeper into what Matten has to offer.

Building on its solid foundation in the food and beverage (F&B) and pharmaceutical industries, Matten understands the critical importance of hygienic system design and adherence to Good Manufacturing Practice (GMP) standards.

With the surge in investment in pharmaceutical manufacturing across Southeast Asia, Matten aims to provide locally assembled Cold WFI systems, supported by regional engineering and service expertise.

Complete Pharmaceutical Water Systems

Matten’s pharmaceutical initiative encompasses comprehensive water systems, covering everything from pre-treatment and high-purity water generation to distribution and post-use treatment.

These systems are designed, engineered, and assembled right here in Southeast Asia, allowing Matten to blend advanced pharmaceutical water treatment technology with local manufacturing, engineering, and after-sales support.

At the core of this initiative is Matten’s Cold WFI technology, which offers an energy-efficient alternative to traditional thermal distillation methods while adhering to globally recognized pharmacopoeial standards, including the European Pharmacopoeia (Ph. Eur.) and the United States Pharmacopeia (USP).

By eliminating the need for constant steam generation and hot water storage, this membrane-based technology not only cuts down on energy consumption and operating costs but also helps reduce carbon emissions.

Regional Engineering and Lifecycle Support

With a strong presence in over six Southeast Asian countries and regional production facilities, Matten is here to support you throughout the entire system lifecycle.

From the initial design and commissioning of systems to ongoing servicing and future upgrades, we provide pharmaceutical manufacturers with valuable access to local technical expertise.

Wider Water Quality and Sustainability Technologies

In addition to our pharmaceutical water systems, Matten is excited to showcase technologies that tackle broader water quality, wastewater treatment, and sustainability challenges.

One highlight is our online rapid bacterial analyzer, which offers near real-time monitoring of Legionella risk in cooling towers, delivering results in as little as 20 minutes.

We’ll also be presenting innovative solutions for sludge treatment and biogas optimization, nitrous oxide (N₂O) emissions monitoring and control, AI-driven polymer dosing, and industrial water reuse.

All of these solutions are crafted to help industrial operators enhance water resilience, ensure compliance with wastewater regulations, and meet environmental performance standards.

Matten’s foray into Cold WFI marks an exciting expansion of our water treatment capabilities into the pharmaceutical sector, focusing on integrating membrane-based technology with locally provided engineering, manufacturing, and lifecycle support throughout Southeast Asia.